Once again you stop giving a drug after two weeks.
The trials are the perfect way to control the outcomes in favor of BP. The very second a drug goes into an FDA trial it is in the control of the FDA. Blind trials, select locations, not allowed to see data, so BP can change protocol, what data is looked at, what patients are chosen, trial lengths, etc., then asking for more data. All in control of FDA and special fees for approval paid upfront in deals made in private without Congress control. w
With billions of dollars at stake, what possibly could wrong.